TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 225 ALZHEIMER'S DISEASE MANAGEMENT CENTER DEMONSTRATION PROGRAM CODE SECTION 225.3000 RESIDENT ASSESSMENT
Section 225.3000 Resident Assessment
a) The facility shall establish policies and procedures defining the assessment process.
b) Prior to admission, each prospective resident shall receive a complete physical examination with specific laboratory testing as follows:
1) Vitamin B12 and Folate levels;
2) Thyroid stimulating hormone level;
3) Complete blood count and blood parameters;
4) Electrocardiogram, 12 lead;
5) Chest radiologic study; and
6) Magnetic Resonance Imaging (MRI) study of the brain, when possible.
c) Within two weeks after admission, each resident shall be assessed by a neurologist, a registered nurse, a psychiatrist and a care manager. A family member or other individual with knowledge about the resident shall participate in the assessment.
d) The neurologist, with input from the registered nurse, shall determine the resident's need for evaluation by a dietician or for other specialized medical evaluations. The assessment shall be coordinated with the pre-admission assessment to the extent possible to avoid duplicative testing.
e) The assessment shall be used, along with the pre-admission assessment, to develop the resident's comprehensive care plan. At four-week intervals, the resident's status shall be reviewed by the facility's nursing, social service and activities and recreation staff.
f) In addition to the assessments required in subsections (c) and (d) of this Section, an Alzheimer's Disease Management Center shall conduct and document an assessment of each resident every six months. The assessment conducted shall include an evaluation of the following:
1) daily functioning,
2) cognitive status, and
3) behavioral problems. (Section 35(5) of the Act)
g) Assessment outcomes shall be reported to appropriate personnel and to the resident and/or resident's representative. |